Literature DB >> 18148240

Chorioretinopathy associated with other evidence of cerebral damage in childhood; a syndrome of unknown etiology separable from congenital toxoplasmosis.

A B SABIN, H A FELDMAN.   

Abstract

Entities:  

Keywords:  BRAIN/diseases; RETINOCHOROIDITIS

Mesh：

Year:  1949        PMID： 18148240     DOI： 10.1016/s0022-3476(49)80002-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  [Experiences and statistical comments on the sero-color test of Sabin and Feldman].

Authors:  H KUDICKE; W POHLIG
Journal:  Z Hyg Infektionskr       Date:  1954

2.  [Malformation of intracranial vessels in a newborn infant].

Authors:  J POLLTER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1954

3.  Ophthalmologic findings in Aicardi syndrome.

Authors:  Gary Fruhman; Tanya N Eble; Nikki Gambhir; V Reid Sutton; Ignatia B Van den Veyver; Richard A Lewis
Journal:  J AAPOS       Date:  2012-06       Impact factor: 1.220

4.  [Toxopasmosis].

Authors:  F KOCH; J SCHORN; G ULE
Journal:  Dtsch Z Nervenheilkd       Date:  1951-09

Review 5.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

6.  [Histology of toxoplasmosis of skin; with reference to the whole literature on toxoplasmosis].

Authors:  H REICH
Journal:  Arch Dermatol Syph       Date:  1952

7.  In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.

Authors:  Seon-Ju Yeo; ChunMei Jin; SungYeon Kim; Hyun Park
Journal:  Korean J Parasitol       Date:  2016-04-30       Impact factor: 1.341

8.  Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System.

Authors:  Justin M Brooks; Gabriela L Carrillo; Jianmin Su; David S Lindsay; Michael A Fox; Ira J Blader
Journal:  mBio       Date:  2015-10-27       Impact factor: 7.867
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.